Tao Sun, Quchang Ouyang, Yehui Shi, Li Cai, Jin Yang, Yongsheng Wang, Lijia He, Fan Feng, Yang Yu, Shaoying Hao, Xunqiang Wang. "Culmerciclib (CDK2/4/6 inhibitor) plus fulvestrant in HR+/HER2− advanced breast cancer after progression on CDK4/6i: Preliminary results from a phase II trial.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.1082